Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2004, p. 1329-1334, Vol. 48, No. 4
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.4.1329-1334.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand,1 Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, Oxford University, Oxford, United Kingdom2
Received 15 September 2003/ Returned for modification 5 November 2003/ Accepted 9 December 2003
The
activities of primaquine in combination with quinine or artesunate
against asexual- and sexual-stage parasites were assessed in 176 adult
Thai patients with uncomplicated Plasmodium falciparum
malaria. Patients were randomized to one of the six following 7-day
oral treatment regimens: (i) quinine alone, (ii) quinine with
tetracycline, (iii) quinine with primaquine at 15 mg/day, (iv) quinine
with primaquine at 30 mg/day, (v) artesunate alone, or (vi) artesunate
with primaquine. Clinical recovery occurred in all patients. There were
no significant differences in fever clearance times, rates of P.
falciparum reappearance, or recurrent vivax malaria between the
six treatment groups. Patients treated with artesunate alone or in
combination with primaquine had significantly shorter parasite
clearance times (mean ± standard deviation = 65
± 18 versus 79 ± 21 h) and lower gametocyte
carriage rates (40 versus 62.7%) than those treated with quinine
(P
0.007). Primaquine did not affect the therapeutic
response (P > 0.2). Gametocytemia was detected in 98
patients (56% [22% before treatment and 34%
after treatment]). Artesunate reduced the appearance of
gametocytemia (relative risk [95% confidence
interval] = 0.34 [0.17 to 0.70]), whereas
combinations containing primaquine resulted in shorter gametocyte
clearance times (medians of 66 versus 271 h for quinine
groups and 73 versus 137 h for artesunate groups; P
0.038). These results suggest that artesunate predominantly
inhibits gametocyte development whereas primaquine accelerates
gametocyte clearance in P. falciparum
malaria.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»